{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T17:33:53Z","timestamp":1795196033748,"version":"4.10.3"},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>To derive systematic review informed, modified Delphi consensus regarding monitoring and replacement of specific coagulation factors during pediatric extracorporeal membrane oxygenation (ECMO) support for the Pediatric ECMO Anticoagulation CollaborativE.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DATA SOURCES:<\/jats:title>\n            <jats:p>A structured literature search was performed using PubMed, Embase, and Cochrane Library (CENTRAL) databases from January 1988 to May 2020, with an update in May 2021.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>STUDY SELECTION:<\/jats:title>\n            <jats:p>Included studies assessed monitoring and replacement of antithrombin, fibrinogen, and von Willebrand factor in pediatric ECMO support.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DATA EXTRACTION:<\/jats:title>\n            <jats:p>Two authors reviewed all citations independently, with conflicts resolved by a third reviewer if required. Twenty-nine references were used for data extraction and informed recommendations. Evidence tables were constructed using a standardized data extraction form.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DATA SYNTHESIS:<\/jats:title>\n            <jats:p>Risk of bias was assessed using the Quality in Prognosis Studies tool. The evidence was evaluated using the Grading of Recommendations Assessment, Development, and Evaluation system. A panel of 48 experts met over 2 years to develop evidence-based recommendations and, when evidence was lacking, expert-based consensus statements. A web-based modified Delphi process was used to build consensus via the Research And Development\/University of California Appropriateness Method. Consensus was defined as greater than 80% agreement. We developed one weak recommendation and four expert consensus statements.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>There is insufficient evidence to formulate recommendations on monitoring and replacement of antithrombin, fibrinogen, and von Willebrand factor in pediatric patients on ECMO. Optimal monitoring and parameters for replacement of key hemostasis parameters is largely unknown.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/pcc.0000000000003492","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T14:13:09Z","timestamp":1720015989000},"page":"e35-e43","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["Recommendations on Monitoring and Replacement of Antithrombin, Fibrinogen, and Von Willebrand Factor in Pediatric Patients on Extracorporeal Membrane Oxygenation: The Pediatric Extracorporeal Membrane Oxygenation Anticoagulation CollaborativE Consensus Conference"],"prefix":"10.1097","volume":"25","author":[{"given":"Nicole D.","family":"Zantek","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie E.","family":"Steiner","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Divisions of Hematology and Critical Care, University of Minnesota, Minneapolis, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Teruya","sequence":"additional","affiliation":[{"name":"Division of Transfusion Medicine and Coagulation, Texas Children\u2019s Hospital and Baylor College of Medicine, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa Baumann","family":"Kreuziger","sequence":"additional","affiliation":[{"name":"Versiti Blood Research Institute and Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Raffini","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Hematology, The Children\u2019s Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Muszynski","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Critical Care Medicine, Nationwide Children\u2019s Hospital and The Ohio State University of Medicine, Columbus, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peta M. A.","family":"Alexander","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Boston Children\u2019s Hospital, Boston, MA."},{"name":"Department of Pediatrics, Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Gehred","sequence":"additional","affiliation":[{"name":"Grant Morrow III MD Medical Library, Nationwide Children\u2019s Hospital, Columbus, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Lyman","sequence":"additional","affiliation":[{"name":"Grant Morrow III MD Medical Library, Nationwide Children\u2019s Hospital, Columbus, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Watt","sequence":"additional","affiliation":[{"name":"Division of Critical Care, Department of Pediatrics and Division of Clinical Pharmacology, University of Utah School of Medicine, Salt Lake City, UT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Pediatric ECMO Anticoagulation CollaborativE (PEACE), in collaboration with the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network, the Pediatric Critical Care Blood Research Network (BloodNet), and the Pediatric ECMO subgroup of PALISI and the Extracorporeal Life Support Organization (PediECMO)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,7,3]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/PCC.0000000000000317","article-title":"Association of bleeding and thrombosis with outcome in extracorporeal life support.","volume":"16","author":"Dalton","year":"2015","journal-title":"Pediatr Crit Care Med"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1164\/rccm.201609-1945OC","article-title":"Factors associated with bleeding and thrombosis in children receiving extracorporeal membrane oxygenation.","volume":"196","author":"Dalton","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/PCC.0000000000002073","article-title":"Mortality and factors associated with hemorrhage during pediatric extracorporeal membrane oxygenation.","volume":"21","author":"O\u2019Halloran","year":"2020","journal-title":"Pediatr Crit Care Med"},{"key":"R4-20250502","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/PCC.0000000000002696","article-title":"Anticoagulation and transfusion management during neonatal and pediatric extracorporeal membrane oxygenation: A survey of medical directors in the United States.","volume":"22","author":"Ozment","year":"2021","journal-title":"Pediatr Crit Care Med"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/PCC.0000000000003480","article-title":"Pediatric Extracorporeal Membrane Oxygenation (ECMO) Anticoagulation CollaborativE (PEACE), in collaboration with the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network, the Pediatric Critical Care Blood Research Network (BloodNet), and the Pediatric ECMO subgroup of PALISI and the Extracorporeal Life Support Organization (PediECMO): Executive summary: The Pediatric Extracorporeal Membrane Oxygenation Anticoagulation CollaborativE Consensus Conference.","volume":"25","author":"Alexander","year":"2024","journal-title":"Pediatr Crit Care Med"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials.","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","article-title":"Assessing bias in studies of prognostic factors.","volume":"158","author":"Hayden","year":"2013","journal-title":"Ann Intern Med"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence.","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"R10-20250502","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jclinepi.2015.11.017","article-title":"A guide for health professionals to interpret and use recommendations in guidelines developed with the GRADE approach.","volume":"72","author":"Neumann","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"R11-20250502","doi-asserted-by":"crossref","first-page":"i2089","DOI":"10.1136\/bmj.i2089","article-title":"GRADE evidence to decision (EtD) frameworks: A systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines.","volume":"353","author":"Alonso-Coello","year":"2016","journal-title":"BMJ"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13012-016-0462-y","article-title":"The GRADE evidence-to-decision framework: A report of its testing and application in 15 international guideline panels.","volume":"11","author":"Neumann","year":"2016","journal-title":"Implement Sci"},{"key":"R13-20250502","doi-asserted-by":"crossref","first-page":"i2016","DOI":"10.1136\/bmj.i2016","article-title":"GRADE evidence to decision (EtD) frameworks: A systematic and transparent approach to making well informed healthcare choices. 1: Introduction.","volume":"353","author":"Alonso-Coello","year":"2016","journal-title":"BMJ"},{"key":"R14-20250502","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2013.12.002","article-title":"Defining consensus: A systematic review recommends methodologic criteria for reporting of Delphi studies.","volume":"67","author":"Diamond","year":"2014","journal-title":"J Clin Epidemiol"},{"key":"R16-20250502","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1111\/jth.15052","article-title":"Anticoagulant and signaling functions of antithrombin.","volume":"18","author":"Rezaie","year":"2020","journal-title":"J Thromb Haemost"},{"key":"R17-20250502","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.3390\/ijms22084283","article-title":"Antithrombin and its role in host defense and inflammation.","volume":"22","author":"Schlommer","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R18-20250502","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/35038119","article-title":"Structure of a serpin-protease complex shows inhibition by deformation.","volume":"407","author":"Huntington","year":"2000","journal-title":"Nature"},{"key":"R19-20250502","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.biochi.2010.05.011","article-title":"Molecular mechanisms of antithrombin-heparin regulation of blood clotting proteinases. A paradigm for understanding proteinase regulation by serpin family protein proteinase inhibitors.","volume":"92","author":"Olson","year":"2010","journal-title":"Biochimie"},{"key":"R20-20250502","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1055\/s-0038-1625983","article-title":"Risk of venous thrombosis in antithrombin deficiency: A systematic review and Bayesian meta-analysis.","volume":"44","author":"Croles","year":"2018","journal-title":"Semin Thromb Hemost"},{"key":"R21-20250502","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1182\/blood.V72.5.1651.1651","article-title":"Development of the human coagulation system in the healthy premature infant.","volume":"72","author":"Andrew","year":"1988","journal-title":"Blood"},{"key":"R22-20250502","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1182\/blood.V70.1.165.165","article-title":"Development of the human coagulation system in the full-term infant.","volume":"70","author":"Andrew","year":"1987","journal-title":"Blood"},{"key":"R23-20250502","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1182\/blood.V80.8.1998.1998","article-title":"Maturation of the hemostatic system during childhood.","volume":"80","author":"Andrew","year":"1992","journal-title":"Blood"},{"key":"R24-20250502","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1177\/0267659120939758","article-title":"Antithrombin use during pediatric cardiac extracorporeal membrane oxygenation admission: Insights from a national database.","volume":"36","author":"Aiello","year":"2021","journal-title":"Perfusion"},{"key":"R25-20250502","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/PCC.0000000000000322","article-title":"Antithrombin concentrates use in children on extracorporeal membrane oxygenation: A retrospective cohort study.","volume":"16","author":"Wong","year":"2015","journal-title":"Pediatr Crit Care Med"},{"key":"R26-20250502","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1097\/PCC.0000000000000955","article-title":"Antithrombin concentrate use in pediatric extracorporeal membrane oxygenation: A multicenter cohort study.","volume":"17","author":"Wong","year":"2016","journal-title":"Pediatr Crit Care Med"},{"key":"R27-20250502","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1097\/MAT.0000000000001340","article-title":"Antithrombin dose optimization in extracorporeal membrane oxygenation in infants.","volume":"67","author":"Liviskie","year":"2021","journal-title":"ASAIO J"},{"key":"R28-20250502","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1051\/ject\/201850030","article-title":"Anticoagulation management during first five days of infant-pediatric extracorporeal life support.","volume":"50","author":"Bingham","year":"2018","journal-title":"J Extra Corpor Technol"},{"key":"R29-20250502","first-page":"717","article-title":"Evaluation of heparin anti-factor Xa levels following antithrombin supplementation in pediatric patients supported with extracorporeal membrane oxygenation.","volume":"25","author":"Gordon","year":"2020","journal-title":"J Pediatr Pharmacol Ther"},{"key":"R30-20250502","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1097\/PCC.0000000000002383","article-title":"Antithrombin dosing guidelines in children underestimate dose needed for plasma level increase.","volume":"21","author":"Mattke","year":"2020","journal-title":"Pediatr Crit Care Med"},{"key":"R31-20250502","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/0391398819888932","article-title":"Exogenous supplementation of antithrombin III in adult and pediatric patients receiving extracorporeal membrane oxygenation.","volume":"43","author":"Sorial","year":"2020","journal-title":"Int J Artif Organs"},{"key":"R32-20250502","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jpedsurg.2016.10.047","article-title":"Outcomes following routine antithrombin III replacement during neonatal extracorporeal membrane oxygenation.","volume":"52","author":"Stansfield","year":"2017","journal-title":"J Pediatr Surg"},{"key":"R33-20250502","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/MAT.0000000000000476","article-title":"The use of recombinant antithrombin III in pediatric and neonatal ECMO patients.","volume":"63","author":"Todd Tzanetos","year":"2017","journal-title":"ASAIO J"},{"key":"R34-20250502","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/PCC.0000000000000278","article-title":"The use of an extracorporeal membrane oxygenation anticoagulation laboratory protocol is associated with decreased blood product use, decreased hemorrhagic complications, and increased circuit life.","volume":"16","author":"Northrop","year":"2015","journal-title":"Pediatr Crit Care Med"},{"key":"R35-20250502","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/MAT.0000000000000010","article-title":"Antithrombin III supplementation on extracorporeal membrane oxygenation: Impact on heparin dose and circuit life.","volume":"60","author":"Byrnes","year":"2014","journal-title":"ASAIO J"},{"key":"R36-20250502","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/MAT.0000000000000099","article-title":"Administration of antithrombin concentrate in infants and children on extracorporeal life support improves anticoagulation efficacy.","volume":"60","author":"Ryerson","year":"2014","journal-title":"ASAIO J"},{"key":"R37-20250502","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.jpedsurg.2012.11.037","article-title":"Antithrombin III administration in neonates with congenital diaphragmatic hernia during the first three days of extracorporeal membrane oxygenation.","volume":"48","author":"Perry","year":"2013","journal-title":"J Pediatr Surg"},{"key":"R38-20250502","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/j.1525-1594.2011.01384.x","article-title":"Antithrombin replacement during extracorporeal membrane oxygenation.","volume":"35","author":"Niebler","year":"2011","journal-title":"Artif Organs"},{"key":"R39-20250502","first-page":"513","article-title":"Use of a novel anticoagulation strategy during ECMO in a pediatric population: Single-center experience.","volume":"52","author":"Agati","year":"2006","journal-title":"ASAIO J"},{"key":"R40-20250502","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/MAT.0b013e318279854a","article-title":"Anticoagulation monitoring during pediatric extracorporeal membrane oxygenation.","volume":"59","author":"Bembea","year":"2013","journal-title":"ASAIO J"},{"key":"R41-20250502","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s001340100991","article-title":"Coagulation factor activity during neonatal extra-corporeal membrane oxygenation.","volume":"27","author":"Arnold","year":"2001","journal-title":"Intensive Care Med"},{"key":"R42-20250502","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1097\/MAT.0000000000001124","article-title":"Comparison of antithrombin III products in pediatric patients receiving extracorporeal membrane oxygenation.","volume":"66","author":"Omecene","year":"2020","journal-title":"ASAIO J"},{"key":"R43-20250502","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1097\/CCM.0000000000004590","article-title":"A randomized controlled trial of antithrombin supplementation during extracorporeal membrane oxygenation.","volume":"48","author":"Panigada","year":"2020","journal-title":"Crit Care Med"},{"key":"R44-20250502","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/PCC.0b013e318219681d","article-title":"Identifying factors to minimize phlebotomy-induced blood loss in the pediatric intensive care unit.","volume":"13","author":"Valentine","year":"2012","journal-title":"Pediatr Crit Care Med"},{"key":"R45-20250502","doi-asserted-by":"crossref","first-page":"e20162480","DOI":"10.1542\/peds.2016-2480","article-title":"Controlling phlebotomy volume diminishes PICU transfusion: Implementation processes and impact.","volume":"140","author":"Steffen","year":"2017","journal-title":"Pediatrics"},{"key":"R46-20250502","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.tmrv.2020.03.003","article-title":"A narrative review on hospital-acquired anemia: Keeping blood where it belongs.","volume":"34","author":"Shander","year":"2020","journal-title":"Transfus Med Rev"},{"key":"R47-20250502","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1161\/ATVBAHA.117.308564","article-title":"Fibrinogen and fibrin in hemostasis and thrombosis.","volume":"37","author":"Kattula","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R48-20250502","first-page":"23","article-title":"Fibrinogen replacement therapy: A critical review of the literature.","volume":"10","author":"Franchini","year":"2012","journal-title":"Blood Transfus"},{"key":"R49-20250502","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-0030-1248720","article-title":"Fibrinogen and the risk of thrombosis.","volume":"36","author":"de Moerloose","year":"2010","journal-title":"Semin Thromb Hemost"},{"key":"R50-20250502","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1213\/ANE.0b013e31822e1853","article-title":"Fibrinogen and hemostasis: A primary hemostatic target for the management of acquired bleeding.","volume":"114","author":"Levy","year":"2012","journal-title":"Anesth Analg"},{"key":"R51-20250502","doi-asserted-by":"crossref","first-page":"647680","DOI":"10.3389\/fped.2021.647680","article-title":"Pediatric fibrinogen PART II-overview of indications for fibrinogen use in critically ill children.","volume":"9","author":"Crighton","year":"2021","journal-title":"Front Pediatr"},{"key":"R52-20250502","doi-asserted-by":"crossref","first-page":"617500","DOI":"10.3389\/fped.2021.617500","article-title":"Pediatric fibrinogen PART I-pitfalls in fibrinogen evaluation and use of fibrinogen replacement products in children.","volume":"9","author":"Huisman","year":"2021","journal-title":"Front Pediatr"},{"key":"R53-20250502","doi-asserted-by":"crossref","first-page":"e886","DOI":"10.1097\/CCM.0000000000003968","article-title":"Quantifiable bleeding in children supported by extracorporeal membrane oxygenation and outcome.","volume":"47","author":"Nellis","year":"2019","journal-title":"Crit Care Med"},{"key":"R54-20250502","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40560-015-0071-x","article-title":"Risk factors associated with intracranial hemorrhage in neonates with persistent pulmonary hypertension on ECMO.","volume":"3","author":"Doymaz","year":"2015","journal-title":"J Intensive Care"},{"key":"R55-20250502","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1177\/0267659109346667","article-title":"Risk factors for bleeding in pediatric post-cardiotomy patients requiring ECLS.","volume":"24","author":"Nardell","year":"2009","journal-title":"Perfusion"},{"key":"R56-20250502","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1051\/ject\/199830283","article-title":"Hematological abnormalities in neonatal patients treated with extracorporeal membrane oxygenation (ECMO).","volume":"30","author":"Zavadil","year":"1998","journal-title":"J Extra Corpor Technol"},{"key":"R57-20250502","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/0885066615601977","article-title":"The impact and statistical analysis of a multifaceted anticoagulation strategy in children supported on ECMO: Performance and pitfalls.","volume":"32","author":"Kessel","year":"2017","journal-title":"J Intensive Care Med"},{"key":"R58-20250502","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s00383-020-04694-0","article-title":"Thromboelastography-guided management of coagulopathy in neonates with congenital diaphragmatic hernia supported by extracorporeal membrane oxygenation.","volume":"36","author":"Phillips","year":"2020","journal-title":"Pediatr Surg Int"},{"key":"R59-20250502","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/ejcts\/ezy408","article-title":"Acquired von Willebrand syndrome in paediatric patients during mechanical circulatory support.","volume":"55","author":"Kubicki","year":"2019","journal-title":"Eur J Cardiothorac Surg"},{"key":"R60-20250502","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/PCC.0000000000002009","article-title":"Acquired von Willebrand syndrome in pediatric extracorporeal membrane oxygenation patients: A single institution\u2019s experience.","volume":"20","author":"Ruth","year":"2019","journal-title":"Pediatr Crit Care Med"},{"key":"R61-20250502","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S0022-3476(95)70205-9","article-title":"Coagulation factor deficiencies during initiation of extracorporeal membrane oxygenation.","volume":"126","author":"McManus","year":"1995","journal-title":"J Pediatr"}],"container-title":["Pediatric Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PCC.0000000000003492","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T18:02:25Z","timestamp":1746208945000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PCC.0000000000003492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/pcc.0000000000003492","relation":{},"ISSN":["1529-7535"],"issn-type":[{"value":"1529-7535","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]}}}